MEDVi vs Gala GLP-1 (2026): Verified Pricing & Best Fit
By the Weight Loss Provider Guide editorial team — an independent comparison resource for GLP-1 telehealth providers. Re-verified monthly.
If you’ve been searching “MEDVi vs Gala GLP-1,” you’ve probably seen what Reddit regulars see: people who used MEDVi, then spotted Gala advertised for less, and now can’t tell if they’re different companies, a better deal, or a red flag. Here’s the answer before anything else.
Gala is the better fit if your top filter is the lowest cash-pay price for compounded tirzepatide and you can commit to a 3-month or annual plan. Roughly $2,148 a year on the annual plan, or $199/month on a 3-month plan.
MEDVi is the better fit if you want a deeper medication menu — compounded injections and dissolvable tablets, plus a $99 membership path to FDA-approved Wegovy® and Zepbound® that Gala doesn’t currently offer. Compounded GLP-1 injections start at $179 your first month.
Neither is your best path if you specifically want FDA-approved medication with insurance support. For that, Ro is the cleaner route — start for $39, then as low as $74/month with the annual plan paid upfront. Medication cost is separate.
And the Reddit question — “are MEDVi and Gala the same company?” — has a real answer most pages won’t give you: they are different legal entities, but both work with clinicians from OpenLoop Health’s network, and MEDVi’s official partner pharmacy list includes RedRock Pharmacy in St. George, Utah — the same pharmacy multiple Gala customers name in their public reviews. We cover exactly what this means for your decision below.
Verify plan length and billing date before paying.
Not sure yet? Take our free 60-second matching quiz →
At-a-glance: MEDVi vs Gala GLP-1
Answer capsule: On compounded tirzepatide, Gala’s annual plan offers the lower long-term cash price ($179/month). MEDVi has the broader medication menu — including dissolvable tablets and a $99 path to FDA-approved Wegovy® and Zepbound®. Both display LegitScript approval badges and hold BBB F ratings. MEDVi received an FDA warning letter on February 20, 2026 for misbranded marketing language; Gala did not appear in the FDA’s published list of warned firms.
Verified April 28, 2026. Verify current pricing on each provider’s site before enrolling.
| Decision factor | MEDVi | Gala GLP-1 |
|---|---|---|
| Compounded tirzepatide / GLP-1+GIP (entry price) | Starts at $179 first month for GLP-1 injection programs (refill pricing set at checkout) | $179/month on 12-month prepay · $199/month on a 3-month plan |
| Compounded oral / dissolvable tablets | ✅ Yes — starts at $249 | ❌ Not currently offered (Wegovy pill "coming soon") |
| Microdose tier | ❌ Not advertised | ✅ $149/month on annual prepay |
| FDA-approved branded path | $99 membership + medication cost for Wegovy® pill, Wegovy® injection, Zepbound® injection | Ozempic® at $1,299/month only; Wegovy pill "coming soon" |
| HRT integrated for menopause | ❌ No | ✅ Yes — estradiol, progesterone, more |
| Cancellation cutoff | 72 hours before next billing date | 72 hours before next billing date |
| Refund policy | Full refund if medically disqualified; no other refunds upon cancellation | Refund eligibility limited per published terms |
| Trustpilot | 4.4 stars · 11,574 reviews | 4.6 stars · 787 reviews |
| BBB rating | F (non-accredited, 452 complaints filed) | F (non-accredited, 12 complaints filed) |
| FDA warning letter | ⚠️ Yes — Letter #721455, 02/20/2026 | ✅ Not on FDA's published list |
| Affiliated medical group | OpenLoop Health, CareGLP Affiliated P.C.s | OpenLoop-affiliated medical practices and other independent groups |
| Pharmacy partners (publicly disclosed) | Triad Rx, RedRock Pharmacy, Beaker Pharmacy | Nationwide network; RedRock referenced in customer reviews |
| LegitScript approval badge | ✅ Displayed | ✅ Displayed |
Pricing pulled from each provider’s public pages on April 28, 2026. Verify the exact dollar amount at checkout before paying — these change.
Are MEDVi and Gala GLP-1 the same company?
Answer capsule: No. MEDVi is operated by MEDVi, LLC, headquartered in Newark, Delaware. Gala GLP-1 is operated by AI Coaching, Inc., headquartered in Wilmington, Delaware. They are separate legal entities with different founders, websites, refund policies, and billing systems. However, both work with clinicians from OpenLoop Health’s network, and MEDVi’s official partner pharmacy list includes RedRock Pharmacy — the same pharmacy multiple Gala customers name in their public Trustpilot reviews. Backend infrastructure may overlap. Ownership does not.
This is the question driving most of the searches that land on this page. A Reddit thread on r/glp1 captures the moment it becomes a concern: a customer used MEDVi, then saw Gala advertised for half the price, signed up because the savings were real, and then noticed the support flow felt familiar. That’s a legitimate buyer concern — not proof of shared ownership.
What’s verified
- • MEDVi is registered as MEDVi, LLC, Newark, Delaware.
- • Gala is registered as AI Coaching, Inc., d/b/a Gala GLP-1, Wilmington, Delaware.
- • MEDVi: “OpenLoop Health clinicians retain the decision to prescribe compounded GLP-1s to patients.”
- • Gala: medical services by “licensed physicians and clinicians affiliated with independently owned and operated medical practices, including OpenLoop-affiliated medical groups.”
- • MEDVi’s official partner pharmacy list publicly includes RedRock Pharmacy (St. George, UT). Multiple Gala Trustpilot reviewers have referenced receiving medication from RedRock Pharmacy by name.
What’s not verified
- • Same ownership. No public evidence the same individuals or holding company own both.
- • Same medication for every patient. Pharmacy assignment varies by state, dose, and timing.
- • Same support team. Similar workflows can result from shared vendor stacks without shared staff.
How much does MEDVi actually cost vs Gala GLP-1?
Answer capsule: MEDVi’s compounded GLP-1 injection program starts at $179 for your first month; refill pricing varies and is set at checkout. Compounded oral tablets start at $249. FDA-approved Wegovy® and Zepbound® are available through a $99 monthly membership plus medication cost. Gala’s compounded GLP-1/GIP (tirzepatide) is $179/month on a 12-month prepaid plan or $199/month on a 3-month plan. The microdose tier is $149/month on annual prepay. The headline prices look similar — the plan-length math is not.
MEDVi: cheap month one, more for refills
MEDVi’s structure is a classic introductory-rate model. The $179 you see in the ad is the first-month price for compounded GLP-1 injections. From month two onward, the per-month price is set at checkout based on your selected medication and plan length. Independent reviews have reported MEDVi’s compounded semaglutide refills in the $299/month range on monthly billing, with annual prepay reducing the effective monthly cost. Tirzepatide refill pricing has been reported higher. Confirm the exact refill amount on your checkout screen before paying.
Compounded oral / dissolvable tablets start at $249. Branded medications use a different model: $99 monthly membership plus the cost of the medication for Wegovy® pill, Wegovy® injection, and Zepbound® injection.
Gala: stable monthly price, but the headline requires annual prepay
Gala’s $179/month is not a first-month rate. It’s the price you pay every month — as long as you’ve prepaid 12 months upfront. Pay on a 3-month plan and you’ll see $199/month. The microdose tier is $149/month on annual prepay. Brand-name Ozempic® on Gala is $1,299/month.
The 12-month math, with the assumption visible
| Plan | Monthly amount | 12-month total |
|---|---|---|
| MEDVi compounded GLP-1 injection (monthly billing, sema reported $179 → $299 refill) | $179 → $299 | ~$3,468 |
| MEDVi compounded oral / dissolvable tablets (monthly billing) | $249 → varies | Verify at checkout |
| MEDVi Wegovy®/Zepbound® | $99 membership + medication | Variable — branded medication priced separately |
| Gala compounded GLP-1/GIP (annual prepay) | $179/mo flat | $2,148 |
| Gala compounded GLP-1/GIP (3-month plan) | $199/mo | $2,388 |
| Gala microdose tier (annual prepay) | $149/mo flat | $1,788 |
Hidden costs to ask about
- Lab work. MEDVi’s terms say lab services may be included; Gala uses similar language. Verify during intake.
- Shipping. MEDVi states shipping is free; Gala doesn’t lead with shipping language — verify before paying.
- Dose escalation. Both providers state higher recommended doses don’t add to your monthly cost. Verify for your specific plan at checkout.
- Cancellation timing. Both require cancellation at least 72 hours before your next billing date. Miss that window and you’re charged for another cycle.
What MEDVi’s FDA warning letter actually means
Answer capsule: On February 20, 2026, the FDA sent MEDVi Warning Letter #721455. The letter cited misbranding — specifically, that medication labels displaying “MEDVi” implied MEDVi was the compounder, and that website language including “Same active ingredient as Wegovy® and Ozempic®” implied FDA approval of compounded products. The letter did not cite a recall, patient injury, or manufacturing failure. MEDVi was one of more than 30 telehealth companies warned in the same March 3, 2026 enforcement wave. Gala GLP-1 was not on the FDA’s publicly announced list of warned firms.
What the letter actually said
The FDA reviewed MEDVi’s website (medvi.io) in December 2025 and identified two specific problems:
- Compounded medication labels showed “MEDVi” branding, implying MEDVi was the compounding entity. MEDVi is not a compounder — medications come from Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding.
- Site language used phrases like “Same active ingredient as Wegovy® and Ozempic®” — the FDA said these imply FDA approval or evaluation of compounded products that have not been FDA-approved.
The letter classified these as misbranding under sections 502(a) and 502(bb) of the Federal Food, Drug, and Cosmetic Act. It required corrective action within 15 working days. It did not cite a recall, patient-injury finding, or manufacturing-failure finding.
The honest reframe
MEDVi does not win on regulatory optics. If clean compliance signaling is your top filter, Gala (not on the published list) or an FDA-approved path through Ro is the better fit.
But why the letter probably matters less than the headlines suggest: the FDA’s complaint was about how MEDVi described medications on its website, not a medication safety event. MEDVi’s medication is dispensed by the same regulated compounding pharmacy network that supplies a meaningful share of the compounded GLP-1 industry. LegitScript continues to display approval for MEDVi after the warning letter. MEDVi has 500,000+ patients and 11,574 Trustpilot reviews at 4.4 stars.
Ro: get started for $39, then as low as $74/month with annual plan paid upfront. Medication cost is separate.
Which pharmacy or provider group will actually handle my prescription?
Answer capsule: MEDVi publicly lists three partner pharmacies — Triad Rx, RedRock Pharmacy, and Beaker Pharmacy & Compounding — and uses OpenLoop Health clinicians (operating as CareGLP Affiliated P.C.s) for prescribing. Gala publicly states it works with a nationwide network of pharmacies and uses OpenLoop-affiliated clinicians, but doesn’t publish a specific partner pharmacy list. Customers at both companies have reported receiving medication from RedRock Pharmacy, indicating supply-chain overlap.
MEDVi’s published structure
MEDVi’s official pages name three pharmacies it works with:
- Triad Rx (Daphne, AL)
- RedRock Pharmacy (St. George, UT)
- Beaker Pharmacy & Compounding (McKinney, TX)
For prescribing, MEDVi states that OpenLoop Health clinicians review eligibility and retain the prescribing decision. One detail worth knowing: Triad Rx is named in a November 2025 class-action complaint against OpenLoop Health alleging that compounded oral tirzepatide tablets lack a viable absorption pathway. The case is unresolved. If you specifically want oral tirzepatide tablets, this is context to weigh.
Gala’s published structure
Gala states it works with a wide network of pharmacies across all 50 states but does not publish a specific pharmacy list. Multiple Gala customers in public Trustpilot reviews have referenced receiving medication from RedRock Pharmacy by name.
Ask both providers before paying
- Which specific pharmacy will fill my prescription for my state and dose?
- Is the pharmacy a 503A or 503B facility?
- Will the medication arrive properly refrigerated?
- What’s the procedure if the medication arrives damaged?
What real customers complain about at Gala GLP-1
Answer capsule: Gala holds a 4.6-star Trustpilot rating across 787 reviews — strong, but on a much smaller volume than MEDVi’s 11,574. Documented complaints cluster around three themes: dose-adjustment requests being delayed or ignored, refund friction after early cancellation, and microdose-tier patients reporting little or no weight loss. Positive reviews praise the in-app tracker, fast shipping with proper cold-pack handling, and notably accessible night-and-weekend customer support.
The most concerning complaint pattern at Gala isn’t billing or shipping — it’s microdose patients not losing weight, and dose-adjustment requests getting stuck.
Multiple verified Trustpilot reviewers describe transferring in from another provider at a higher dose, providing documentation, and being prescribed starter doses anyway. Gala’s $149/month microdose tier is positioned as a low-dose longevity protocol — not as their standard active-weight-loss plan. Several reviewers signed up expecting active weight loss, didn’t see results, and felt misled.
Other documented friction:
- Refund friction for patients who canceled early or received vials that arrived partially full.
- Pricing surprises at checkout — several reviewers reported the advertised price didn’t match what they were charged. Usually plan-length confusion ($179 annual vs $199 quarterly).
- App glitches — the Gala GLP-1 Tracker app holds approximately a 3.9-star iOS rating and 3.7-star Android rating, with reports of login loops and food-tracking inconsistencies.
The reframe: If you’re a straightforward case — adult, no complex medical history, want standard-dose compounded tirzepatide, comfortable with a 3-month or annual commitment — Gala is a clean fit. If you’re transferring care at a higher dose, include your dose history and current pharmacy clearly in your intake.
MEDVi vs Gala GLP-1: full feature comparison
Answer capsule: MEDVi offers a broader medication menu (including dissolvable oral tablets and a $99 path to FDA-approved Wegovy® and Zepbound®), a much larger Trustpilot review base, and a refund only for medical disqualification. Gala offers stable monthly pricing, integrated HRT for menopause, an in-app tracker, and a microdose tier MEDVi doesn’t publish. Both display LegitScript approval and hold HIPAA-compliant privacy practices.
| Feature | MEDVi | Gala GLP-1 |
|---|---|---|
| Compounded GLP-1 injection (entry price) | Starts at $179 first month | $179/mo annual prepay or $199/mo 3-month plan |
| Compounded oral / dissolvable tablets | Yes — starts at $249 | Not currently offered |
| Microdose tier | Not advertised | Yes — $149/mo on annual prepay |
| Brand-name FDA-approved medications | Wegovy® pill, Wegovy® injection, Zepbound® injection ($99 membership + medication cost) | Ozempic® at $1,299/mo; Wegovy pill "coming soon" |
| Insurance billing | No — cash-pay only | No — cash-pay only |
| HSA/FSA accepted | Listed on landing page (verify at checkout) | Not prominently advertised (verify during intake) |
| Telehealth model | Async with on-request synchronous | Sync video for first visit (state-dependent), async after |
| Mobile app | Patient portal | Yes — Gala GLP-1 Tracker (~3.9 stars iOS) |
| HRT for menopause integrated | No | Yes — estradiol pill/patch, progesterone, vaginal estradiol, non-hormonal options |
| Cancellation cutoff | 72 hours before next billing date | 72 hours before next billing date |
| Refund after cancellation | Full refund if medically disqualified; no other refunds upon cancellation | Refund eligibility limited per published terms |
| Trustpilot rating | 4.4 / 5 across 11,574 reviews | 4.6 / 5 across 787 reviews |
| BBB rating | F (non-accredited, 452 complaints filed) | F (non-accredited, 12 complaints filed) |
| LegitScript approval | ✅ Displayed | ✅ Displayed |
| FDA warning letter | ⚠️ Yes — Letter #721455, 02/20/2026 | ✅ Not on FDA's published list |
| Stated patient base | 500,000+ patients | 50,000+ success stories cited |
Who wins between MEDVi and Gala — by your situation
Answer capsule: There is no single winner. MEDVi wins on menu depth, dissolvable tablets, the $99 path to FDA-approved branded medication, and review volume. Gala wins on the lowest 12-month cost for tirzepatide on annual prepay, integrated HRT for menopause, a published microdose tier, and stable monthly pricing without a first-month promo. The right answer depends on which filter you’re optimizing for.
If you want the broadest medication menu
It's the only one of the two with dissolvable tablets and the only one with a $99 membership path to FDA-approved Wegovy® and Zepbound® if you decide later that compounded isn't for you. Gala's branded option is Ozempic® at $1,299/month — useful only for a narrow group.
Start MEDVi intake →If you want the lowest 12-month price on tirzepatide
$2,148 a year on the annual prepay plan is the cheapest published path of the two for compounded tirzepatide. The catch is the upfront commitment — if there's any chance you'll stop in month two, the math changes.
Lock in Gala's annual price →If you're already looking for HRT alongside GLP-1 care
Gala publishes an integrated path through estradiol pill or patch, progesterone, vaginal estradiol, and non-hormonal options for hot flashes — all on the same platform as your GLP-1 program. MEDVi does not currently offer equivalent women's hormone services.
Start Gala intake →If you want microdose or low-dose tirzepatide specifically
The published $149/month microdose tier is a real product MEDVi doesn't compete on. Just be honest about the goal: Gala positions microdose as a low-dose longevity protocol — not their standard active-weight-loss plan.
See Gala's microdose plan →If you want a $99 path to FDA-approved Wegovy® or Zepbound®
The $99 membership plus medication cost is the only path of the two that gets you FDA-approved branded weight-loss medication without leaving the platform. Verify the current branded medication availability at intake — supply varies.
Start MEDVi intake →If you want a stable monthly price without the first-month-promo bump
Gala's $179 (annual) and $199 (3-month) prices are flat — they don't jump after month one. MEDVi's $179 is an entry price; refills are higher. Several Trustpilot reviewers cite this exact pattern as their reason for switching.
See Gala's plan options →If you want the largest patient base for review-volume confidence
500,000+ patients claimed and 11,574 Trustpilot reviews give you a much larger base of customer experiences to read through. Gala's 787 reviews are positive on average but a smaller dataset.
Start MEDVi intake →If you specifically want FDA-approved branded medication with insurance support
Pick neither — pick Ro. Both MEDVi and Gala primarily prescribe compounded medications that are not FDA-approved as finished products. Ro carries Foundayo™ (orforglipron), Wegovy® pill, Wegovy® pen, Zepbound® pen, and Zepbound® KwikPen — with a free GLP-1 Insurance Coverage Checker and insurance concierge that handles prior-authorization paperwork.
Check insurance coverage at Ro →Get started for $39, then as low as $74/month with annual plan paid upfront. Medication cost is separate.
Not sure yet? Take our 60-second matching quiz. We’ll route you to the right provider based on price tolerance, medication preference, insurance status, and commitment comfort.
Take the matching quiz →Compounded vs FDA-approved: what you’re actually buying
Answer capsule: Both MEDVi and Gala primarily prescribe compounded semaglutide and tirzepatide. Compounded medications are prepared by licensed pharmacies under Section 503A of the Federal Food, Drug, and Cosmetic Act and are not FDA-approved as finished products. FDA-approved Wegovy®, Ozempic®, Mounjaro®, and Zepbound® have been evaluated through the FDA’s full pre-market review. The two product categories are not interchangeable.
A compounded medication is one prepared by a licensed compounding pharmacy to meet a specific patient’s needs. Section 503A pharmacies operate under state and federal regulations but are not subject to the FDA’s pre-market review process that applies to brand-name medications.
Brand-name semaglutide (Wegovy®, Ozempic®, Rybelsus®) is manufactured by Novo Nordisk under FDA-approved processes. Brand-name tirzepatide (Mounjaro®, Zepbound®) is manufactured by Eli Lilly under FDA-approved processes. Both have completed clinical trials demonstrating specific efficacy and safety profiles for the FDA-approved branded products.
Trust signals: BBB, Trustpilot, and the LegitScript badge
Answer capsule: Both MEDVi and Gala hold F ratings from the Better Business Bureau and are not BBB-accredited — MEDVi shows 452 complaints filed; Gala shows 12. Both display LegitScript approval badges. MEDVi has a 4.4-star Trustpilot rating across 11,574 reviews. Gala has a 4.6-star rating across 787 reviews. Read all four signals together, not one in isolation.
| Signal | MEDVi | Gala GLP-1 |
|---|---|---|
| Trustpilot | 4.4 / 5 · 11,574 reviews | 4.6 / 5 · 787 reviews |
| BBB rating | F · Not accredited · 452 complaints | F · Not accredited · 12 complaints |
| LegitScript | ✅ Displayed | ✅ Displayed |
| FDA warning letter | ⚠️ Yes — Feb 20, 2026 (misbranding) | ✅ Not on published list |
Cancellation, refunds, and the fine print
Answer capsule: Both MEDVi and Gala require cancellation at least 72 hours before your next billing date. Both auto-renew. MEDVi’s published policy provides a full refund only for medical disqualification — no other refunds upon cancellation. Gala’s terms similarly limit refund eligibility after prescription medication has been dispensed. Screenshot the plan terms before paying, set a calendar reminder 5–7 days before your billing date, and save written cancellation confirmation.
| Term | MEDVi | Gala GLP-1 |
|---|---|---|
| Cancellation cutoff | 72 hours before next billing date | 72 hours before next billing date |
| Auto-renews? | Yes | Yes |
| Refund on cancellation | No — except medical disqualification | Limited per published terms; less clear after medication dispensed |
| Medical disqualification refund | Full refund of remaining subscription charges | Similar provisions per published terms |
The cancellation checklist — save this before you sign up
Before paying, screenshot the following on the provider’s confirmation screen:
- The exact plan name (e.g., “compounded GLP-1/GIP, 12-month prepay”)
- The exact dollar amount being charged today
- Your next billing date
- The cancellation cutoff (typically 72 hours before billing)
- The refund policy for unused months and for medical disqualification
- The medication category (compounded vs branded) and formulation
- The pharmacy or fulfillment source if shown
- The provider group reviewing your prescription
- The support contact (email and phone if available)
- The billing descriptor that will appear on your card statement
What real customers say about each
Answer capsule: MEDVi reviews most consistently praise quick approval, kind support staff, and clinician responsiveness. Most consistent MEDVi complaints involve the price jump from first-month promo to refill pricing, billing for unrequested refills, and difficulty obtaining refunds. Gala reviews most consistently praise stable pricing, the in-app tracker, fast shipping with cold-pack handling, and accessible night-and-weekend customer service. Most consistent Gala complaints involve dose-adjustment delays, microdose-only patients not losing weight, and refund difficulty.
MEDVi — verified review themes
Trustpilot’s own AI summary of MEDVi reviews highlights staff professionalism, customer service helpfulness, and ease of managing refills and appointments. The opposite pattern also appears: delayed prescriptions, double-charges, and customer-service runarounds. At MEDVi’s scale, both experiences are real. Straightforward cases likely fall into the first group; complex cases (billing disputes, dose changes) require more advocacy.
Gala GLP-1 — verified review themes
A verified Trustpilot reviewer wrote: “By far the best GLP company and accessible customer service on nights and weekends.” — a real differentiator most cash-pay telehealth platforms can’t claim. The dose-escalation friction is worth noting: multiple reviewers describe transferring in at higher doses with documentation and being prescribed starter doses anyway. If you’re transferring care, include your dose history clearly in your intake notes.
What you must verify before paying
Use this list at either provider’s checkout:
- What medication category am I being prescribed? Compounded or FDA-approved? They are different products with different regulatory status.
- What is the exact formulation? Injection, dissolvable tablet, microdose?
- What is being charged today? The dollar amount on the confirmation screen, not the marketing-page headline.
- What is the next billing amount? First-month promo or stable pricing?
- What is the next billing date? And what time zone?
- What is the cancellation cutoff? 72 hours is the published standard at both providers — confirm it matches your renewal date.
- What’s the refund policy if I’m medically disqualified after intake?
- What’s the refund policy if I cancel after the medication ships?
- Does my dose change affect the price?
- Which pharmacy will fill my prescription?
- Which provider group reviews my medical history?
- What’s the support phone number and email?
If any of these answers don’t match what you expected from the marketing page, don’t pay yet. Reach out to support. Both companies respond to clarification questions.
MEDVi vs Gala GLP-1: frequently asked questions
Is Gala GLP-1 cheaper than MEDVi?
On long-term compounded tirzepatide, yes. Gala's annual prepay plan is $179/month ($2,148/year). MEDVi's compounded semaglutide refills have been reported around $299/month on monthly billing. The exception is month one: MEDVi's $179 first-month entry price for compounded GLP-1 injection is the cheapest way to start.
Are MEDVi and Gala the same company?
No. MEDVi is operated by MEDVi, LLC, based in Newark, Delaware. Gala GLP-1 is operated by AI Coaching, Inc., based in Wilmington, Delaware. They are separate legal entities with different founders, websites, and billing systems. However, both work with clinicians from OpenLoop Health's network, and MEDVi's official partner pharmacy list includes RedRock Pharmacy in St. George, Utah — the same pharmacy multiple Gala customers name in their public Trustpilot reviews. Backend infrastructure may overlap; ownership does not.
Is MEDVi legit after the FDA warning letter?
MEDVi displays LegitScript approval, has more than 500,000 patients, and a 4.4-star Trustpilot rating across 11,574 reviews. The February 20, 2026 FDA Warning Letter (#721455) cited misbranded marketing language — specifically that medication labels implied MEDVi was the compounder, and website language implied FDA approval of compounded products. The letter required corrective action within 15 working days. It did not cite a recall, patient injury, or manufacturing failure. MEDVi was one of more than 30 telehealth companies warned in the same enforcement wave.
Is Gala GLP-1 legit?
Gala displays LegitScript approval, HIPAA-compliant privacy practices, and a 4.6-star Trustpilot rating across 787 reviews. Gala did not appear in the FDA's publicly announced list of 30 telehealth companies warned in March 2026. Documented complaints include dose-adjustment delays, microdose-only patients not losing weight, and refund friction after early cancellation. Compounded GLP-1 medications are not FDA-approved finished products — that applies to every compounded provider.
Which has better tirzepatide pricing — MEDVi or Gala?
Both prescribe compounded tirzepatide as a weekly injection. Gala wins on long-term price: $179/month on annual prepay ($2,148/year) or $199/month on a 3-month plan. MEDVi wins on patient base size, dissolvable tablet availability, and the $99 path to FDA-approved Mounjaro®/Zepbound®. Gala does not currently offer branded tirzepatide.
Can you cancel MEDVi or Gala GLP-1 easily?
Both providers require cancellation at least 72 hours before your next billing date. Both auto-renew unless canceled. Cancellation through the patient portal is straightforward when timed correctly; most complaints arise from patients who missed the 72-hour window. Set a calendar reminder 5–7 days before your billing date and save written confirmation.
Does insurance cover MEDVi or Gala GLP-1?
Neither provider bills insurance. Both are cash-pay only. HSA/FSA cards may be accepted — verify at intake. For insurance-covered FDA-approved Wegovy or Zepbound, Ro's GLP-1 Insurance Coverage Checker is the clearest path. Ro membership is $39 first month, then $149/month or as low as $74/month with annual prepay; medication cost is separate.
Are compounded GLP-1 medications FDA-approved?
No. Compounded versions of semaglutide and tirzepatide are not FDA-approved as finished products. They are prepared by licensed compounding pharmacies under Section 503A of the Federal Food, Drug, and Cosmetic Act. The FDA does not review compounded medications for safety, effectiveness, or quality before marketing. Both MEDVi and Gala disclose this on their websites.
What happens if I’m medically disqualified after I pay MEDVi or Gala?
At MEDVi, the published refund policy provides a refund of the remainder of your subscription charges if you're medically disqualified by their provider. Gala's published terms include similar disqualification provisions. If the refund doesn't process automatically, contact support and reference the specific policy language.
Should I pick MEDVi or Gala if I’m in menopause?
Gala — if you want HRT support alongside GLP-1 care. Gala publishes an integrated path through estradiol pill or patch, progesterone, vaginal estradiol, and non-hormonal options for hot flashes and night sweats — coordinated on the same platform with your GLP-1 program. MEDVi does not currently offer equivalent women's hormone services.
What's the difference between Gala's microdose plan and the regular plan?
Gala's $149/month microdose tier uses a lower dose of compounded GLP-1/GIP than the $179/month standard plan. Gala positions microdose as a low-dose longevity protocol. Documented Trustpilot complaints from microdose-only patients indicate that some signed up expecting active weight loss and didn't see results. If your goal is meaningful weight reduction, the standard tier ($179/month annual or $199/month on a 3-month plan) is the appropriate starting point.
The bottom line: MEDVi vs Gala GLP-1
MEDVi is the broader platform — more medications, dissolvable tablets, and a $99 path to FDA-approved Wegovy® or Zepbound®. Trade-offs: price jump after month one (verify exact refill pricing at checkout) and the FDA marketing-language warning letter.
Gala is the simpler, often cheaper platform — strongest 12-month math on tirzepatide on annual prepay, the only one of the two with a published microdose tier, and the only one with integrated HRT for menopause. Trade-offs: smaller patient base and documented complaints from microdose-only patients about insufficient weight loss and dose-adjustment friction.
Both companies work with clinicians from OpenLoop Health’s network. Both display LegitScript approval. Both prescribe compounded medications that are not FDA-approved as finished products.
Not sure? Take our free 60-second matching quiz →
What we actually verified for this comparison
Last updated: . Next scheduled review: May 28, 2026.
Verified directly:
- MEDVi pricing pulled from glp.medvi.org on April 28, 2026
- Gala pricing pulled from galaglp1.com on April 28, 2026
- MEDVi cancellation and refund policy at home.medvi.org
- Gala refund policy at galaglp1.com
- FDA Warning Letter #721455 read in full at fda.gov
- FDA’s March 3, 2026 press release announcing 30 warned telehealth firms
- Trustpilot ratings and current review counts for both providers
- BBB profile data for MEDVi, LLC and AI Coaching, Inc. d/b/a Gala GLP-1
- LegitScript badges displayed on both providers’ websites
- MEDVi’s official pharmacy partner list (Triad Rx, RedRock, Beaker)
- Gala’s published OpenLoop affiliation language
- November 2025 OpenLoop / Triad Rx class-action complaint regarding compounded oral tirzepatide
Not verified by us:
- We did not sign up for either service for this comparison.
- We did not lab-test medication from either provider.
- We did not independently audit LegitScript certification status.
Sources
- FDA Warning Letter #721455 to MEDVi (February 20, 2026)
- FDA press release — 30 warning letters to telehealth GLP-1 firms (March 3, 2026)
- STAT News — clinical groups behind FDA telehealth warning letters
- Fierce Healthcare — OpenLoop / Triad Rx oral tirzepatide class action
- Trustpilot — MEDVi
- Trustpilot — Gala GLP-1
- BBB — MEDVi profile
- BBB — AI Coaching, Inc. d/b/a Gala GLP-1 profile
- galaglp1.com — pricing, terms, FAQ
- glp.medvi.org — pricing, partners
- MEDVi cancellation and refund policy
- Gala refund policy
- Ro Body weight loss pricing